Eli Lilly and Novast start facility expansion in Nantong, China

Manufacturing Chemist group

首页> 外文期刊>Manufacturing Chemist: Pharmaceutical Development, Formulation, Processing and Outsourcing >Eli Lilly and Novast start facility expansion in Nantong, China

【24h】

Eli Lilly and Novast start facility expansion in Nantong, China

机译：礼来公司和诺瓦斯特公司在中国南通开始扩建工厂

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Eli Lilly and Chinese pharmaceutical company Novast Laboratories have begun a US$60-70m expansion of manufacturing and development facility capacities in Nantong, Jiangsu, China. The facility will be located on a 22-acre campus inside the Free Trade Zone of the Nantong Economic Technology Development Area (NETDA).

机译：礼来制药公司和中国制药公司Novast Laboratories已开始在中国江苏南通进行60-7000万美元的制造和开发设施产能扩张。该设施将位于南通经济技术开发区（NETDA）自由贸易区内占地22英亩的校园内。

著录项

来源
《Manufacturing Chemist: Pharmaceutical Development, Formulation, Processing and Outsourcing》 |2014年第4期|共1页
作者
Manufacturing Chemist group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类化学工业;
关键词

相似文献

外文文献
中文文献
专利

1. Eli Lilly and Novast start facility expansion in Nantong, China [J] . Manufacturing Chemist group Manufacturing Chemist: Pharmaceutical Development, Formulation, Processing and Outsourcing . 2014,第4期

机译：礼来公司和诺瓦斯特公司在中国南通开始扩建工厂
2. Ardmac wins tender for Eli Lilly biopharmaceutical facility in Cork [J] . Cleanroom technology . 2012,第8期

机译：Ardmac中标美国礼来生物制药厂
3. Evonik buys Eli Lilly facility in Indiana [J] . Process worldwide Group Process worldwide . 2009,第6期

机译：赢创收购了礼来公司在印第安纳州的工厂
4. The LIL Facility Start-Up: First High Power and High Energy Laser Experimental Results at 1053nm and 351 nm [C] . J.M, Di-Nicola, J.P. Leidinger, International Conference on Inertial Fusion Sciences and Applications . 2004

机译：LIL设施启动：第一个高功率和高能激光实验结果1053nm和351nm
5. Economies of Everyday Suffering: Some Implications of Eli Lilly's Zyprexa Market Strategy in US Primary Care. [D] . Fidler, Bradley Reuben. 2011

机译：日常痛苦的经济状况：礼来的Zyprexa市场策略对美国初级保健的一些启示。
6. In Response to Letters to the Editor From the American Diabetes Association and Eli Lilly in Regard to: Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in the Cold Supply Chain [O] . Alan W. Carter, Lutz Heinemann 2018

机译：回应美国糖尿病协会和礼来公司关于以下内容的致编辑的信：美国药房随机购买的小瓶中胰岛素浓度：冷供应链中的可观损失
7. FDA approves Eli Lilly's baricitinib [O] . Asher Mullard 2018

机译：FDA批准Eli Lilly's Baricitinib

Eli Lilly and Novast start facility expansion in Nantong, China

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅